Trial Profile
A study to evaluate distinct [18F] AV1451 retention patterns in clinical variants of Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 15 Oct 2015 New trial record